Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SIONthis companySionna Therapeutics, Inc.	$3.51	-21.88×	5.36×	0×	-21.36×	-67.1%	0.0%	0.0%	0.0%	-24.5%	-28.2%	-4.1%	0.03×	0.67×	0×	20.61×	0.0%	0	4.01	2	C
ARDXArdelyx, Inc.	$2.96	-22.42×	8.42×	3.45×	-53.09×	-5941.7%	89.5%	-10.1%	-15.1%	-36.9%	-9.9%	-3.1%	1.27×	-4.92×	-1.44×	4.31×	0.0%	2	-0.11	1	D+
BHVNBiohaven Ltd.	$15.38	-1.65×	23.33×	0×	-1.75×	-103.9%	0.0%	0.0%	0.0%	-1418.8%	-218.4%	-50.2%	5.47×	-0.08×	0×	3.18×	0.0%	3	-15.51	2	C
CLDXCelldex Therapeutics, Inc.	$30.98	-6.96×	3.43×	1,204.09×	-6.97×	-99.2%	100.0%	-19160.0%	-17253.3%	-49.1%	-53.9%	-11.8%	0×	0.1×	0×	10.49×	0.0%	2	16.42	2	C
IMNMImmunome, Inc.	$19.14	-8.84×	2.96×	270.32×	-5.86×	-62.3%	57.4%	-3084.8%	-3060.0%	-33.5%	-33.5%	-10.7%	0.01×	3.1×	0×	14.69×	0.0%	2	31.88	2	C+
JANXJanux Therapeutics, Inc.	$14.14	-7.54×	0.89×	85.51×	-7.39×	-118.0%	79.7%	-1576.7%	-1136.3%	-11.9%	-16.0%	-9.7%	0.02×	0.27×	0×	39.04×	0.0%	3	8.27	2	C+
Peer median	—	-7.54×	3.43×	85.51×	-6.97×	-103.9%	79.7%	-1576.7%	-1136.3%	-36.9%	-33.5%	-10.7%	0.02×	0.1×	0×	10.49×	0.0%	2	8.27	2	—